30 September 2022
  • 9:19 am Death toll in Florida uncertain as Hurricane Ian takes aim at Carolinas
  • 9:05 am Farmers’ protest in Islamabad enters third day
  • 9:05 am Comedian Trevor Noah announces exit from ‘The Daily Show’
  • 9:04 am PM Modi to flag off Gandhinagar-Mumbai Central Vande Bharat Express: What awaits passengers on this new train service?
  • 8:50 am Why the decision to implement civil and criminal procedure codes in Meghalaya has caused alarm
Choose Language
 Edit Translation
My-Ads
Spread the News

Novavax said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.

Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax’s COVID-19 shot can neutralize the variant, according to the company.

Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.

The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.

Related: ‘Sotrovimab works against Omicron variant of coronavirus’

Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.

Novavax’s COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.

Facebook Notice for EU!
You need to login to view and post FB Comments!

The post Novavax says it could start making Omicron-specific vaccine in January appeared first on ARY NEWS.

Abdul Gh Lone

RELATED ARTICLES